Home NDC 50845-0239-1 Varicose Veins
Product NDC 50845-0239
Requested package NDC 50845-0239-1
11-digit product format 508450239
Labeler code 50845
Product ID 50845-0239_71fd000c-e97f-4e67-a648-5a7911c14aa6
Type HUMAN OTC DRUG
Nonproprietary name Aesculus Hippocastanum, Arnica Montana, Calcarea Fluorica, Calcarea Iodata, Carduus Marianus, Hamamelis Virginiana, Hepar Suis, Hydrofluoricum Acidum, Lachesis Mutus, Millefolium, Pulsatilla (Vulgaris)
Dosage form SPRAY
Route ORAL
Labeler Liddell Laboratories, Inc
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2018-07-18
Marketing end 2023-07-18
Substance HORSE CHESTNUT; ARNICA MONTANA; CALCIUM FLUORIDE; CALCIUM IODIDE; SILYBUM MARIANUM SEED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; PORK LIVER; HYDROFLUORIC ACID; LACHESIS MUTA VENOM; ACHILLEA MILLEFOLIUM; PULSATILLA VULGARIS
Active strength 1 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 14 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Code, Status table Captured / source date Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2020-12-18 03:04 UTC · source 2020-12-17 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50845-0239-1 50845023901 30 mL in 1 BOTTLE, SPRAY (50845-0239-1) 30 ml 2018-07-18 2023-07-18 No No Current